Cerecin is a healthcare company with more than 20 years of innovation and leadership in brain health.
Leveraging the physiological ketone system to provide fuel for the brain.
A diversified and integrated pipeline of products for brain healthcare.
A world-class team of drug developers focused on addressing huge areas of unmet medical need.
ALTER AD is our Phase 3 study investigating tricaprilin in people with mild to moderate Alzheimer's disease.
Learn more about what is happening with Cerecin.
We’re looking for new talent to join our global community.
We appreciate your interest in Cerecin.
KR: [바이오 한파, VC의 선택은]③ 안재열 파트너스인베 상무 “글로벌 생태계 접목해 韓기업의 美 진출 도울 것
Link to Article Here
Korean 
English